InvestorsHub Logo
Followers 121
Posts 12650
Boards Moderated 2
Alias Born 12/21/2017

Re: Ecomike post# 2039

Monday, 12/30/2019 11:55:29 AM

Monday, December 30, 2019 11:55:29 AM

Post# of 2741
$MILV I have been trying to gain more understanding and find more breadcrumbs into this ticker. For those that read these posts and do not know much about the back story of MILV, here is a snippet:

1. In late October, the custodian, Joseph Passaqulua had a shareholder letter that went out to an older shareholder list.

In this, it stated that this company called "Compelling Competitive Advantage LLC (CCA LLC)" would merge with MILV.

2. That CCA LLC had an open contract with University of Pennsylvania and Childrens Hospital of Philly


Interestingly enough, a bunch of us needed to know more about this company and so the digging began.

We found an old company by the name of Endeavor IP (more recently NanoLife Health) was 90% owned by CCA. The major shareholders of the company were listed:

James B. Hovis (sold multiple drinking lines e.g. AQUISS Beverage to Egg. Co)
Edward J. Mathias (Senior Adviser to one of the WORLDS largest investment firms -- The Carlyle Group -- Assets $211 billion AND AND AND A TRUSTER EMERITUS for University of Penn... interesting)
Michael W. Fountain -- (microbiologist in liposome research "a vehicle compound", has 181 products, 131 international and domestic patents, sold a company for $575 million The Liposome Company) to Elan Corp.)
Larry Kubin (Two time superbowl champion with Washington Redskins and advocate and spokesperson for traumatic brain injury)
Stuart Yarbrough (Crosshill Financial Group -- takes startups and gives them the money to build a successful company and makes them look good for big company acquisitions).


What this means is that you have a lot of successful people and big names coming together to build a BIOTECH company to utilize MICHAEL W. FOUNTAINs patents for brain trauma therapy, recovery, prevention/

*****He developed a carrier drug (liposome) that can pass through the BBB - Blood Brain Barrier and deliver highly targeted drugs to neurons prior to neuronal necrosis*****

READ ABOUT IT: MILV CCA Biotech

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.